Skip to main content

Table 6 Outcome in relation to sites of metastatic disease

From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study

Site of Metastasis

# of Patients

Median Survival (mo.)

p – value

Lung

   

   No

64

13.1

.0474

   Yes

31

11.9

 

Liver

   

   No

24

14.7

.5114

   Yes

71

12.7

 

1 Intra-abdominal

   

   No

59

17.1

.0043*

   Yes

36

9.3

 

Lymph Nodes

   

   No

85

13.2

.3319

   Yes

10

12.5

 

# of Metastasis

   

   1

49

17.1

.0009*

   2

35

10.9

 

   3

11

6.5

 
  1. 1Intra-abdominal metastasis refers to disease involving the colon, rectum, pancreas, abdominal wall, bladder, prostate, pelvis or adrenals.